BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15774188)

  • 1. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokine receptor 3 modulates bleomycin-induced pulmonary injury via involving inflammatory process.
    Gao JM; Lu B; Guo ZJ
    Chin Med Sci J; 2006 Sep; 21(3):152-6. PubMed ID: 17086735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
    Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
    Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
    Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.
    Zhang K; Gharaee-Kermani M; McGarry B; Remick D; Phan SH
    J Immunol; 1997 Jan; 158(2):954-9. PubMed ID: 8993016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pulmonary inflammation is inhibited in CXCR3 knockout mice after short-term cigarette smoke exposure.
    Nie L; Xiang RL; Liu Y; Zhou WX; Jiang L; Lu B; Pang BS; Cheng DY; Gao JM
    Acta Pharmacol Sin; 2008 Dec; 29(12):1432-9. PubMed ID: 19026162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of valsartan on bleomycin-induced pulmonary fibrosis in rats and the expression of hepatocyte growth factor in lung tissue].
    Liu F; Xu QY; Ye YQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):479-83. PubMed ID: 16115399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats].
    Zhang DP; Qiu H; Zhuang Y; Meng FQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):197-201. PubMed ID: 17572999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
    Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
    Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
    Wang SJ; Bai W; Wang CL; Dai Z
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
    Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
    Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
    Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.